Lv5
1179 积分 2024-01-08 加入
A breast cancer targeted photodynamic degrader to activate immunotherapy through EGFR degradation mediated PD-L1 downregulation
13天前
已完结
Targeted Drug/Gene/Photodynamic Therapy via a Stimuli‐Responsive Dendritic‐Polymer‐Based Nanococktail for Treatment of EGFR‐TKI‐Resistant Non‐Small‐Cell Lung Cancer
13天前
已完结
Photoinduced Synergism of Ferroptosis/Pyroptosis/Oncosis by an O2-Independent Photocatalyst for Enhanced Tumor Immunotherapy
1个月前
已完结
Effect of Surface Modification on the Luminescence of Individual Upconversion Nanoparticles
1个月前
已完结
Vandetanib for the Treatment of Symptomatic or Progressive Medullary Thyroid Cancer in Patients with Unresectable Locally Advanced or Metastatic Disease: U.S. Food and Drug Administration Drug Approval Summary
3个月前
已完结
Osimertinib: First Global Approval
3个月前
已完结
Development of EGFR Family Small Molecule Inhibitors for Anticancer Intervention: An Overview of Approved Drugs and Clinical Candidates
3个月前
已完结
Deciphering the Intrinsic Chemistry of Protein‐Enhanced Type I Photodynamic Processes
4个月前
已完结
Glutathione/Cysteine Dual‐Consuming Prodrug Nanoassemblies for Potentiated Gas‐Photodynamic Therapy
4个月前
已完结
Effective Degradation of Wild‐Type and Mutant EGFR Using Self‐Assembling Peptide‐Derived PROTAC Nanoparticles (NanoTACs) for Cancer Therapy
4个月前
已完结
皖公网安备34019202002308
